OpenAlex 148 works 1 author topics
Works
148 works
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex top 1%
OpenAlex 99.3%
Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline by using the best approach to integrated care pathways using mobile technology in patients with allergic rhinitis (AR) and asthma multimorbidity. The proposed next phase of ARIA is change management, with the aim of providing an active and…
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex top 1%
OpenAlex 99.3%
No abstract yet.
-
YÖKSİS
SJR Q2
JCR Q2
OpenAlex top 1%
OpenAlex 99.4%
mHealth, such as apps running on consumer smart devices is becoming increasingly popular and has the potential to profoundly affect healthcare and health outcomes. However, it may be disruptive and results achieved are not always reaching the goals. Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a…
-
YÖKSİS
SJR Q2
JCR Q2
OpenAlex top 1%
OpenAlex 99.4%
mHealth, such as apps running on consumer smart devices is becoming increasingly popular and has the potential to profoundly affect healthcare and health outcomes. However, it may be disruptive and results achieved are not always reaching the goals. Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a…
-
OpenAlex top 10%
OpenAlex 98.2%
Abstract MASK‐air ® , a validated mHealth app (Medical Device regulation Class IIa) has enabled large observational implementation studies in over 58,000 people with allergic rhinitis and/or asthma. It can help to address unmet patient needs in rhinitis and asthma care. MASK‐air ® is a Good Practice of DG Santé on dig…
-
YÖKSİS
SJR Q1
JCR Q2
OpenAlex top 10%
OpenAlex 98.2%
Abstract MASK‐air ® , a validated mHealth app (Medical Device regulation Class IIa) has enabled large observational implementation studies in over 58,000 people with allergic rhinitis and/or asthma. It can help to address unmet patient needs in rhinitis and asthma care. MASK‐air ® is a Good Practice of DG Santé on dig…
-
YÖKSİS
SJR Q1
JCR Q2
OpenAlex top 10%
OpenAlex 98.2%
Abstract MASK‐air ® , a validated mHealth app (Medical Device regulation Class IIa) has enabled large observational implementation studies in over 58,000 people with allergic rhinitis and/or asthma. It can help to address unmet patient needs in rhinitis and asthma care. MASK‐air ® is a Good Practice of DG Santé on dig…
-
No abstract yet.
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex top 10%
OpenAlex 95.7%
No abstract yet.
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex top 10%
OpenAlex 95.7%
No abstract yet.
-
YÖKSİS
SJR Q2
JCR Q3
OpenAlex 80.6%
In all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health care effectively. There is a need to support the transformation of the health care system for integrated care with organizational health literacy. MASK (Mobi…
-
YÖKSİS
SJR Q3
JCR Q2
OpenAlex 34.6%
Ziele: Es sollen sowohl Erkrankungen und Beschwerden wie das Behandlungskonzept des Patienten (Überzeugung von der Wirksamkeit und Arzneimittelerwartungen) als auch die Arzneimittelverordnungen von Ärzten in Abhängigkeit von der Zugehörigkeit der Patienten zu den ethnischen Gruppen türkische Immigranten bzw. deutschsp…
Academicians
1 academicians